Oncology

Enhertu, a drug made by AstraZeneca and Daiichi Sankyo, significantly lowered the risk of death or tumor progression among patients with HER2-positive breast cancer, The Wall Street Journal reports. 

The US Oncology Network selected Jason Hammonds as its new president Sept. 20 

President Joe Biden's administration appointed seven clinicians and researchers to the National Cancer Advisory Board Sept. 15. 

Mishawaka, Ind.-based Franciscan Health plans to build a 68,000-square-foot cancer center in Lafayette.

Count Me In, a research initiative that allows cancer patients to share data directly with researchers, launched the Colorectal Cancer Project Sept. 14. 

Among 38 patients with B-cell blood cancers, 21 (55 percent) produced antibodies after receiving a booster dose of an mRNA COVID-19 vaccine despite not producing detectable antibodies after the first two doses, according to a recent study led by the…

Scripps Mercy Hospital San Diego, part of Scripps MD Anderson Cancer Center, opened the $59 million Prebys Cancer Center Sept. 13. 

These three oncologists joined new practices or received new appointments recently.

Recent oncology studies have focused on the severity of COVID-19 illness among pediatric cancer patients, outcomes among cancer patients diagnosed after the pandemic lockdown and more. 

Patients in France who were newly diagnosed with metastatic colorectal cancer after the country's first COVID-19 lockdown in spring 2020 had a higher tumor burden compared to those who were diagnosed before the lockdown, according to research published Sept. 8…